COVID-19: what has been learned and to be learned about the novel coronavirus disease
暂无分享,去创建一个
Ren-He Xu | R. Xu | Y. Yi | Philip N. P. Lagniton | S. Ye | E. Li | Ye Yi | Sen Ye | Enqin Li | P. N. Lagniton
[1] William A. Lee,et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys , 2016, Nature.
[2] Qiang Zhou,et al. Structure of dimeric full-length human ACE2 in complex with B0AT1 , 2020, bioRxiv.
[3] H. Doerr,et al. Stability and inactivation of SARS coronavirus , 2004, Medical Microbiology and Immunology.
[4] A. Ahuja,et al. Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. , 2005, Radiology.
[5] A. Danchin,et al. The Severe Acute Respiratory Syndrome , 2003 .
[6] Hanxiong Guan,et al. Imaging changes in patients with 2019-nCov , 2020, European Radiology.
[7] M. Jackson,et al. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings , 2007, American Journal of Infection Control.
[8] Jue Fan,et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection , 2020, bioRxiv.
[9] Y. Hu,et al. On the use of corticosteroids for 2019-nCoV pneumonia , 2020, The Lancet.
[10] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[11] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[12] Elizabeth Rea,et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.
[13] Y. Guan,et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.
[14] E. Decroly,et al. Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus , 2014, Virus Research.
[15] W. Silverstein,et al. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia , 2020, The Lancet.
[16] Chong-Jen Yu,et al. Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients , 2004, Emerging infectious diseases.
[17] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.
[18] J. Druce,et al. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Catharine I Paules,et al. Coronavirus Infections-More Than Just the Common Cold. , 2020, JAMA.
[20] P. Niu,et al. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient , 2018, The Journal of infectious diseases.
[21] C. Ruppert,et al. Surfactant alteration and replacement in acute respiratory distress syndrome , 2001, Respiratory research.
[22] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[23] Xin Li,et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.
[24] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[25] W. Lu,et al. ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection , 2020, medRxiv.
[26] R. Harley,et al. Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome. , 2003, American journal of respiratory cell and molecular biology.
[27] K. Kedzierska,et al. Suppressor of Cytokine Signaling 4 (SOCS4) Protects against Severe Cytokine Storm and Enhances Viral Clearance during Influenza Infection , 2014, PLoS pathogens.
[28] S. Grupp,et al. Current concepts in the diagnosis and management of cytokine release syndrome. , 2014, Blood.
[29] Z. Memish,et al. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy , 2013, International Journal of Infectious Diseases.
[30] I. Khalid,et al. Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital , 2016, Annals of thoracic medicine.
[31] R. Duval,et al. Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies , 2012, Viruses.
[32] Michael G. Katze,et al. Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.
[33] Ziding Zhang,et al. Isolation and Characterization of 2019-nCoV-like Coronavirus from Malayan Pangolins , 2020, bioRxiv.
[34] Ji’an Pan,et al. SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism , 2010, Virus Genes.
[35] B. Na,et al. Clinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection. , 2019, Japanese journal of infectious diseases.
[36] H. Einsele,et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] E. Dong,et al. An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.
[38] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[39] Y. Waheed,et al. The World after Ebola: An Overview of Ebola Complications, Vaccine Development, Lessons Learned, Financial Losses, and Disease Preparedness. , 2019, Critical reviews in eukaryotic gene expression.
[40] Lisa E. Gralinski,et al. Molecular pathology of emerging coronavirus infections , 2014, The Journal of pathology.
[41] P. Horby,et al. A novel coronavirus outbreak of global health concern , 2020, The Lancet.
[42] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[43] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[44] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[45] P. Yip,et al. A revisit on older adults suicides and Severe Acute Respiratory Syndrome (SARS) epidemic in Hong Kong , 2008, International journal of geriatric psychiatry.
[46] Cheng-wei Lu,et al. 2019-nCoV transmission through the ocular surface must not be ignored , 2020, The Lancet.
[47] C. Gomersall,et al. Protecting healthcare staff from severe acute respiratory syndrome: filtration capacity of multiple surgical masks , 2005, Journal of Hospital Infection.
[48] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[49] J. Baillie,et al. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.
[50] Alimuddin Zumla,et al. Coronaviruses — drug discovery and therapeutic options , 2016, Nature Reviews Drug Discovery.
[51] R. L. Roper,et al. SARS vaccines: where are we? , 2009, Expert review of vaccines.
[52] Tiina Reponen,et al. Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? , 2006, American journal of infection control.
[53] 憲 大久保. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007 , 2008 .
[54] Jianhong Wu,et al. Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions , 2020, Journal of clinical medicine.
[55] Xiao-Ping Dong,et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. , 2003, Biomedical and environmental sciences : BES.
[56] Wei Liu,et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China , 2020, medRxiv.
[57] D. Swerdlow,et al. Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014 , 2016, The American Journal of Pathology.
[58] Ping Chen,et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission , 2020, Science China Life Sciences.
[59] T. Su,et al. Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS caring unit during outbreak: A prospective and periodic assessment study in Taiwan , 2006, Journal of Psychiatric Research.
[60] P. Heeger,et al. Molecules Great and Small: The Complement System. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[61] I. Todorov,et al. HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen , 2008, Proceedings of the National Academy of Sciences.
[62] Fei Deng,et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin , 2020, bioRxiv.
[63] Hans Anton Schlößer,et al. Cytokine release syndrome , 2018, Journal of Immunotherapy for Cancer.
[64] S. Perlman,et al. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.
[65] Christian Drosten,et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.
[66] Lisa E. Gralinski,et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.
[67] Y Chow. Consensus document on the epidemiology of SARS , 2003 .
[68] Linqi Zhang,et al. Antibodies and vaccines against Middle East respiratory syndrome coronavirus , 2019, Emerging microbes & infections.
[69] T. Velavan,et al. The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.
[70] A. Arvey,et al. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses , 2017, Scientific Reports.
[71] Xingguang Li,et al. Cross‐species transmission of the newly identified coronavirus 2019‐nCoV , 2020, Journal of medical virology.
[72] C. D. Dela Cruz,et al. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. , 2020, JAMA.
[73] Christian Drosten,et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group , 2020, bioRxiv.
[74] K. To,et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan , 2020, Emerging microbes & infections.
[75] S. Lo,et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.
[76] X. Hua,et al. Modulation of murine dendritic cell function by adenine nucleotides and adenosine: Involvement of the A2B receptor , 2008, European journal of immunology.
[77] Shan-Chwen Chang. Clinical Findings, Treatment and Prognosis in Patients with Severe Acute Respiratory Syndrome (SARS) , 2005, Journal of the Chinese Medical Association.
[78] Q. Pham,et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam , 2020, The New England journal of medicine.
[79] Ling Zhang,et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed , 2020, The Lancet Psychiatry.
[80] Shibo Jiang,et al. The spike protein of SARS-CoV — a target for vaccine and therapeutic development , 2009, Nature Reviews Microbiology.
[81] Hongzhou Lu,et al. Drug treatment options for the 2019-new coronavirus (2019-nCoV). , 2020, Bioscience trends.
[82] B. Murphy,et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.
[83] N. Hong,et al. Avascular necrosis of bone in severe acute respiratory syndrome , 2004, Clinical Radiology.
[84] F. Lionnet,et al. Lactate dehydrogenase in sickle cell disease. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[85] H. Johnson,et al. Applications of acute phase reactants in infectious diseases. , 1999, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[87] B. Cowling,et al. Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings. , 2006, Archives of internal medicine.
[88] Jie Dong,et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study , 2020, Chinese medical journal.
[89] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[90] D. Falzarano,et al. SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.
[91] Xingguang Li,et al. Cross‐species transmission of the newly identified coronavirus 2019‐nCoV , 2020, Journal of Medical Virology.
[92] Tiantian Han,et al. Coronavirus infections and immune responses , 2020, Journal of medical virology.
[93] B. Cowling,et al. A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes , 2016, PloS one.
[94] M. Farcet,et al. Immunoglobulins and virus antibody titers: of past needs, current requirements, and future options , 2018, Transfusion.
[95] M. Kikkert,et al. Host Factors in Coronavirus Replication , 2017, Current topics in microbiology and immunology.